Qiyu Yang

Title: Qiyu Yang: Innovator in Genetic Engineering

Introduction

Qiyu Yang is a prominent inventor based in Sichuan, China. He has made significant contributions to the field of genetic engineering, particularly in the development of innovative therapeutic solutions for cancer treatment. His work focuses on enhancing the immune response against tumors, showcasing his commitment to advancing medical science.

Latest Patents

Qiyu Yang holds a patent for a "Genetically engineered dual-targeting chimeric antigen receptor and use thereof." This invention addresses the up-regulated expression of PD-L1 in tumor cells and immune cells exposed to malignant serosal cavity effusion. The dual-targeting chimeric antigen receptor developed by Yang is designed to competitively bind to PD-L1, transforming an inhibition signal into an activation signal. This mechanism enhances the killing activity of T cells, while the introduction of 4-1BB promotes T cell proliferation and survival. The patent also includes a host cell expressing this dual-targeting antigen receptor, which can be utilized in preventing or treating solid tumors.

Career Highlights

Qiyu Yang is affiliated with Sichuan University, where he conducts research and develops innovative solutions in genetic engineering. His work has garnered attention for its potential impact on cancer therapies, positioning him as a key figure in the field.

Collaborations

Yang collaborates with notable colleagues, including Yongsheng Wang and Qizhi Ma. Their combined expertise contributes to the advancement of research and development in genetic engineering.

Conclusion

Qiyu Yang's contributions to genetic engineering, particularly through his patented innovations, highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also holds promise for improving cancer treatment outcomes.